We make Cannabinoids accessible.

SynBiotic is a stock listed platform company with a EU focused buy & build investment approach.

why we are different
investor relations

Focus on real consumer problems.

People are looking for solutions to their real-life problems. With cannabinoids we are able to address a multi-billion EU-market for sleep, pain and anxiety solutions with cumulative sales of over € 250 billion for OTC and pharmaceuticals in 2020.

over

0

people with sleep-related problems, such as disturbed sleep

over

0

people with chronic pain and similar issues 

over

0

people with anxiety

SynBiotic Value Chain

SynBiotic’s organizational structure is built to cover all value drivers – from research over production to distribution

Research & Development

Our R&D portfolio consists of leading research facilities, whose scientists are sought-after pioneers in the field of cannabinoids.

Production & Biotech

With a portfolio of production and extraction companies operating cutting-edge facilities, we can guarantee products of the highest quality – a significant competitive advantage.

Distribution

We buy and build strong medical & DTC brands which enable us to distribute our innovative products to customers.

Our Companies

SynBiotic Approach

Beyond Cannabis for a multi-billion market. Regulations, market, and customer readiness make CBD the most promising cannabinoid to start with, building a solid foundation for our platform. But we focus not solely on CBD and THC, but also on other cannabinoids, endocannabinoids and terpenes with high potential.

Why? – Because we want to build the most effective products in the market

Most CBX* have not been discovered yet, but studies show that other cannabinoids, beyond THC and CBD, have huge medical potential. In addition, the so called entourage effectis a term used to describe the synergistic effects of combining various chemical compounds found in cannabis. Most commonly, it refers to the interaction between THC/CBD and other cannabinoids or terpenes.

* CBX = all cannabinoids except THC

Beyond Cannabis & Hemp

While CBD from hemp & cannabis plants is still a legal grey area, we focus in parallel on other plants that are rich in cannabinoids, endocannabinoids & terpenes.

We analysed over 1000 plants and searched for Cannabinoids, Endocannabinoids & Terpenes ...

... AND WE FOUND MANY.

Be a part of our mission

For Ventures

SynBiotic supports & invests in cannabinoid focused ventures and teams. Are you looking for a strong partner?
Contact us!

For Investors

Find out more about our company, its structure, shares and download the latest financial publications.
Investor Relations

Press

back to top

SynBiotic SE – MAKING CANNABINOIDS ACCESSIBLE.
© 2021 Synbiotic SE | All rights reserved

Imprint         Privacy policy